Hydrodilatation, corticosteroids and adhesive capsulitis: a randomized controlled trial.

2.50
Hdl Handle:
http://hdl.handle.net/10143/41696
Title:
Hydrodilatation, corticosteroids and adhesive capsulitis: a randomized controlled trial.
Authors:
Tveitå, Einar Kristian; Tariq, Rana; Sesseng, Sølve; Juel, Niels Gunnar; Bautz-Holter, Erik
Citation:
BMC musculoskeletal disorders 2008, 9:53
Additional Links:
http://www.biomedcentral.com/1471-2474/9/53

Full metadata record

DC FieldValue Language
dc.contributor.authorTveitå, Einar Kristian-
dc.contributor.authorTariq, Rana-
dc.contributor.authorSesseng, Sølve-
dc.contributor.authorJuel, Niels Gunnar-
dc.contributor.authorBautz-Holter, Erik-
dc.date.accessioned2008-12-02T09:47:25Z-
dc.date.available2008-12-02T09:47:25Z-
dc.date.issued2008-
dc.identifier.citationBMC musculoskeletal disorders 2008, 9:53en
dc.identifier.issn1471-2474-
dc.identifier.pmid18423042-
dc.identifier.doi10.1186/1471-2474-9-53-
dc.identifier.urihttp://hdl.handle.net/10143/41696-
dc.description.abstractBACKGROUND: Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to which the reported treatment effects may be attributed. Any important contribution arising from the hydrodilatation procedure itself remains to be demonstrated. METHODS: In this randomized trial, a hydrodilatation procedure including corticosteroids was compared with the injection of corticosteroids without dilatation. Patients were given three injections with two-week intervals, and all injections were given under fluoroscopic guidance. Outcome measures were the Shoulder Pain and Disability Index (SPADI) and measures of active and passive range of motion. Seventy-six patients were included and groups were compared six weeks after treatment. The study was designed as an open trial. RESULTS: The groups showed a rather similar degree of improvement from baseline. According to a multiple regression analysis, the effect of dilatation was a mean improvement of 3 points (confidence interval: -5 to 11) on the SPADI 0-100 scale. T-tests did not demonstrate any significant between-group differences in range of motion. CONCLUSION: This study did not identify any important treatment effects resulting from three hydrodilatations that included steroid compared with three steroid injections alone. TRIAL REGISTRATION: The study is registered in Current Controlled Trials with the registration number ISRCTN90567697.en
dc.language.isoenen
dc.relation.urlhttp://www.biomedcentral.com/1471-2474/9/53en
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Fysikalsk medisin og rehabilitering: 764en
dc.subject.meshAdulten
dc.subject.meshAnti-Inflammatory Agentsen
dc.subject.meshArthrographyen
dc.subject.meshBursitisen
dc.subject.meshDilatationen
dc.subject.meshDisability Evaluationen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshInjections, Intra-Arterialen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPain Measurementen
dc.subject.meshRange of Motion, Articularen
dc.subject.meshShoulder Painen
dc.subject.meshTreatment Outcomeen
dc.subject.meshTriamcinolone Acetonideen
dc.titleHydrodilatation, corticosteroids and adhesive capsulitis: a randomized controlled trial.en
dc.typepeer revieweden
dc.contributor.departmentDepartment of Physical Medicine and Rehabilitation, Ullevål University Hospital, Oslo, Norway. e.k.tveita@medisin.uio.noen
dc.identifier.journalBMC musculoskeletal disordersen
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.